FHCCX Holdings Information

FHCCX is a mutual fund with a total of 133 individual holdings. The top holdings are Eli Lilly and Company stock at 6.94%, Danaher at 6.41%, Boston Scientific at 6.09%, Johnson & Johnson at 5.55%, and AbbVie at 4.30%.

Total Holdings

133

Top 10 Percentage

42.21%

Asset Class

Equity

Fund Category

Health

Assets

2.91B

Forward PE Ratio

22.91

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	6.94%	208,000
2	DHR	Danaher Corporation	6.41%	960,000
3	BSX	Boston Scientific Corporation	6.09%	2,500,000
4	JNJ	Johnson & Johnson	5.55%	705,000
5	ABBV	AbbVie Inc.	4.30%	585,000
6	ASND	Ascendis Pharma A/S	2.74%	370,000
7	EBR: UCB	UCB SA	2.61%	276,000
8	MRK	Merck & Co., Inc.	2.59%	660,000
9	GILD	Gilead Sciences, Inc.	2.55%	540,000
10	ARGX	argenx SE	2.43%	100,000
11	EW	Edwards Lifesciences Corporation	2.19%	800,000
12	CVS	CVS Health Corporation	1.94%	765,000
13	ALNY	Alnylam Pharmaceuticals, Inc.	1.84%	174,000
14	TMO	Thermo Fisher Scientific Inc.	1.78%	108,000
15	COGT	Cogent Biosciences, Inc.	1.58%	1,280,000
16	MCK	McKesson Corporation	1.50%	48,000
17	BTSG	BrightSpring Health Services, Inc.	1.42%	1,080,000
18	VRDN	Viridian Therapeutics, Inc.	1.40%	1,500,000
19	MRNA	Moderna, Inc.	1.36%	800,000
20	INSM	Insmed Incorporated	1.35%	285,000
21	UNH	UnitedHealth Group Incorporated	1.30%	140,000
22	NUVL	Nuvalent, Inc.	1.26%	390,000
23	SWX: ROP	Roche Holding AG	1.24%	82,000
24	COR	Cencora, Inc.	1.18%	100,000
25	RPRX	Royalty Pharma plc	1.08%	740,000

Showing 25 of 133 holdings

Subscribe to see the full list

Activate Now

As of Feb 28, 2026